NRC expected to issue Mo-99 facility license for Shine in 2021

May 13, 2020, 9:10PMNuclear News

Shine Medical Technologies, which is building a medical isotope production facility in Janesville, Wis., said on May 11 that it expects to have an operating license issued by the Nuclear Regulatory Commission by October 2021. Shine’s application seeking approval to operate the facility, which will produce isotopes including molybdenum-99, was accepted and docketed by the NRC last October. Mo-99, the precursor to technetium-99m, is used in more than 40 million medical patient procedures every year.

To continue reading, log in or create a free account!

Related Articles

NRC approves NuScale uprated SMR design

June 2, 2025, 9:30AMNuclear News

NuScale earned approval for its “larger” US460 77-MWe small modular reactor plant design, the Nuclear Regulatory Commission announced last week.The standard design approval (SDA) is a...

NRC news roundup

Summer progress; Waterford news; safety report of Northeast plants

May 16, 2025, 9:30AMNuclear News

Here’s a look at some recent announcements from the Nuclear Regulatory Commission.Summer SLR: The NRC this month published its final environmental impact statement for Summer Unit 1’s...